Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lucia Palmisano"'
Autor:
Vincenzo Fragola, L. E. Weimer, Marina Giuliano, Raffaella Bucciardini, Manuela Pellegrini, Stefano Vella, Mauro Andreotti, Lucia Palmisano, Emilia Marchei, Clementina Maria Galluzzo, Maria Franca Pirillo, Simona Pichini
Publikováno v:
AIDS Research and Human Retroviruses. 26:541-545
Emergence of resistance is one of the drawbacks associated with treatment interruptions (TI), especially when regimens include nonnucleoside reverse transcriptase inhibitors (NNRTIs), because of their long half-life. ISS-PART was a randomized trial c
Autor:
Lucia Palmisano, Stefano Vella
Publikováno v:
Clinical Infectious Diseases. 41:S239-S246
Since 1989 the emergence of resistant human immunodeficiency virus mutants has been documented for any new antiretroviral agent introduced in the clinical setting; it is a major cause of failure of antiretroviral therapy that may ultimately compromis
Autor:
Saverio Giuseppe Parisi, Clementina Maria Galluzzo, Ercole Concia, Vincenzo Vullo, Emanuele Nicastri, Marco Montano, Roberta Amici, Stefano Vella, Lucia Palmisano, Massimo Andreoni, Ilaria Uccella, Francesca Gatti, Loredana Sarmati, Gabriella d'Ettorre
Whether highly active antiretroviral therapy (HAART) should be modified in patients with persistent increases in CD4 + T cells despite detectable viral loads is an unresolved question. Forty-three heavily pretreated human immunodeficiency virus (HIV)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::def32285650c6a53ff9c52cb3ea91c22
http://hdl.handle.net/2108/49470
http://hdl.handle.net/2108/49470
Autor:
Ercole Concia, Clementina Maria Galluzzo, Emanuele Nicastri, Vincenzo Vullo, Saverio Giuseppe Parisi, Ilaria Uccella, Massimo Andreoni, Loredana Sarmati, Gabriella d'Ettorre, Lucia Palmisano, Stefano Vella
In 32 patients for whom highly active antiretroviral therapy was failing, a good agreement between drug resistance-associated mutations in plasma and peripheral blood mononuclear cells (PBMCs) was found ( k = 0.85). The mutations with the lowest agre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efb95c7dcbb6c59e37580cc40c63b8fe
http://hdl.handle.net/11577/153158
http://hdl.handle.net/11577/153158
Autor:
Gabriella d'Ettorre, Gabriele Forcina, Loredana Sarmati, Mauro Andreotti, Stefano Vella, Vincenzo Vullo, Lucia Palmisano, Claudio Maria Mastroianni, Emanuele Nicastri, Massimo Andreoni, Clementina Maria Galluzzo
Objective: To study virologic and immunologic factors associated with discordant treatment response in HIV-infected patients receiving highly active antiretroviral therapy (HAART). Design: Study participants included a total of 27 patients: (a) 10 di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bb7450ebed07faa1526e7c47f1476c8
http://hdl.handle.net/2108/49479
http://hdl.handle.net/2108/49479
Autor:
Anne-Mieke, Vandamme, Ricardo J, Camacho, Francesca, Ceccherini-Silberstein, Andreu, de Luca, Lucia, Palmisano, Dimitrios, Paraskevis, Roger, Paredes, Mario, Poljak, Jean-Claude, Schmit, Vincent, Soriano, Hauke, Walter, Anders, Sönnerborg, Mike, Youle
Publikováno v:
Europe PubMed Central
Università degli Studi di Siena-IRIS
Università degli Studi di Siena-IRIS
The European HIV Drug Resistance Guidelines Panel, established to make recommendations to clinicians and virologists, felt that sufficient new information has become available to warrant an update of its recommendations, explained in both pocket guid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1a2ca2c2c919aed88341f719331fd2c9
http://europepmc.org/abstract/med/21587341
http://europepmc.org/abstract/med/21587341
Autor:
Milos Opravil, Lee T. Bacheler, Jonathan M. Schapiro, A Horban, William W. Hall, A. De Luca, N. Dedes, E. Shulse, M Youle, Giorgio Gatti, T. W. Myers, Tomás Pumarola, Angelos Hatzakis, Ricardo Jorge Camacho, Carlo Federico Perno, Jean-Claude Schmit, Rainer Ziermann, Michael D. Miller, Nathan Clumeck, Schlomo Staszewski, Vincent Soriano, Mika Salminen, Jan Albert, Luc Perrin, Jean-Louis Faudon, Jan Gerstoft, Nicholas S. Hellmann, Lidia Ruiz, Deenan Pillay, P. Clevenbergh, Veronica Miller, Anne-Mieke Vandamme, Françoise Brun-Vézinet, Stefano Vella, Barbara Schmidt, Jens D Lundgren, Hans Wilhelm Doerr, Lucia Palmisano, Rob Schuurman, Dénes Bánhegyi, Dale J. Kempf, Anders Sönnerborg, Andrew N. Phillips, Claus Nielsen, Birgitta Åsjö, Mounir Ait-Khaled, Charles A. Boucher
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
ResearcherID
Web of Science
Università degli Studi di Siena-IRIS
Scopus-Elsevier
ResearcherID
Web of Science
Università degli Studi di Siena-IRIS
In most European countries, HIV drug resistance testing has become a routine clinical tool. However, its practical implementation in a clinical context is demanding. The European HIV Drug Resistance Panel was established to make recommendations to cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bc7674da7f2d1435c9a1c82776d2440
http://europepmc.org/abstract/med/15651743
http://europepmc.org/abstract/med/15651743